Adoptive T‐cell therapy targeting Epstein–Barr virus as a treatment for multiple sclerosis

Abstract excerpt

Emergence of a definitive link between Epstein-Barr virus (EBV) and multiple sclerosis has provided an impetus to develop immune-based therapies to target EBV-infected B cells. Initial studies with autologous EBV-specific T-cell therapy demonstrated that this therapy is safe with minimal side effects and more importantly multiple patients showed both symptomatic and objective neurological improvements including...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to CAR-T cell therapy research
• Share to Polyomavirus and related diseases
• Share to T-cell and Retrovirus Studies